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H2S releasing molecules inhibits inflammation and calcification of valvular interstitial cells.
H2S inhibits inflammation and calcification in aortic valve of apolipoprotein E deficient mice.
H2S suppresses nuclear translocation of NF-jB and subsequent expression of IL-1b and TNF-a.
Activation of Runx2, its nuclear translocation is mediated by NF-jB in calcifying conditions.
Inflammation and calcification are connected via master transcription factors, NF-jB and Runx2.g r a p h i c a l a b s t r a c ta r t i c l e i n f o
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Introduction: Hydrogen sulfide (H2S) was revealed to inhibit aortic valve calcification and inflammation
was implicated in the pathogenesis of calcific aortic valve disease (CAVD).
Objectives: We investigate whether H2S inhibits mineralization via abolishing inflammation.valvular
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Apolipoprotein E knockout miceMethods and results: Expression of pro-inflammatory cytokines, interleukin-1 (IL-1) and tumor necrosis
factor (TNF-) were increased in patients with CAVD and in calcified aortic valve of ApoE-/- mice.
Administration of H22S releasing donor (4-methoxyphenyl piperidinylphosphinodithioc acid (AP72))
exhibited inhibition on both calcification and inflammation in aortic valve of apolipoprotein E knockout
mice (ApoE-/-) mice is reflected by lowering IL-1 and TNF- levels. Accordingly, AP72 prevented the accu-
mulation of extracellular calcium deposition and decreased nuclear translocation of nuclear factor-B
(NF-B) in human valvular interstitial cells (VIC). This was also accompanied by reduced cytokine
response. Double-silencing of endogenous H2S producing enzymes, Cystathionine gamma-lyase (CSE)
and Cystathionine beta-synthase (CBS) in VIC exerted enhanced mineralization and higher levels of IL-
1 and TNF-. Importantly, silencing NF-B gene or its pharmacological inhibition prevented nuclear translo-
cation of runt-related transcription factor 2 (Runx2) and subsequently the calcification of human VIC.
Increased levels of NF-B and Runx2 and their nuclear accumulation occurred in ApoE-/- mice with a
high-fat diet. Administration of AP72 decreased the expression of NF-B and prevented its nuclear translo-
cation in VIC of ApoE-/- mice on a high-fat diet, and that was accompanied by a lowered pro-
inflammatory cytokine level. Similarly, activation of Runx2 did not occur in VIC of ApoE-/- mice treated
with H2S donor. Employing Stimulated Emission Depletion (STED) nanoscopy, a strong colocalization of
NF-B and Runx2 was detected during the progression of valvular calcification.
Conclusions: Hydrogen sulfide inhibits inflammation and calcification of aortic valve. Our study suggests
that the regulation of Runx2 by hydrogen sulfide (CSE/CBS) occurs via NF-B establishing a link between
inflammation and mineralization in vascular calcification.
 2020 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction ical and pathological conditions including CAVD [21]. In our previ-Calcific aortic valve disease (CAVD) is the most common indica-
tion for surgical aortic valve replacement in the world [1]. CAVD is
particularly dominant in national populations over age 65 (2–7%)
[2] and also a frequent disorder in chronic kidney disease (CKD)
[3]. The percentage of CAVD has been increasing in the last 10 years
and the incidence of the disease expected to increase in the future
[4–7]. Surgical intervention remains the only available option to
treat CAVD while efficient conservative therapy is lacking [8–13].
In calcific aortic valve disease, the valvular interstitial cells
transdifferentiate into osteoblast-like cells contributing to the
mineralization of tissue [1,9]. Nuclear translocation of osteogenic
transcription factor Runx2 initiates the transition of cells towards
an osteoblast phenotype in response to various pathological stim-
uli such as high phosphate [14].
It has been revealed by O’Brien et al. that pro-inflammatory
cytokines, interleukin-1b (IL-1b) and tumor necrosis factor a
(TNF-a) are associated with CAVD, and inflammation is a hallmark
of CAVD [15–17]. Furthermore, Rajamannan and colleagues in the
National Heart, Lung, and Blood Institute provided novel insights of
CAVD. They demonstrated that CAVD is an active complex osteo-
genic process and inflammation plays a central role in its initiation
and progression. It was shown that abnormal hemodynamic forces
such as shear stress, hypertension or elevated stretch experienced
by the valve leaflets can cause tissue remodeling and inflamma-
tion, consequently may lead to calcification, stenosis and heart
valve failure [1,2,9]. Additionally, immunohistochemistry analysis,
based on 285 CAVD patient’s heart valve, indicated that 28.4% of
affected specimens of CAVD are characterized by massive leuko-
cytes infiltration and high expression of TNF-a as a resulting
chronic inflammation [17]. In an animal model of IL-1Ra
(interleukin-1 receptor antagonist) deficiency in mice an enflamed
aortic valve stenosis was shown to occur, and TNF-a participated
in the pathogenesis of valvular mineralization [18].
The induction of the signaling pathway of nuclear factor-jB
(NF-jB) is one of the main mediators of inflammation that plays
a critical role in the development and progression of CAVD [19].
Nuclear translocation of NF-jB induced by TNF-a promotes inor-
ganic phosphate-induced calcification in human aortic smooth
muscle cells [20].
H2S is a third gasotransmitter among nitrogen-oxide and
carbon-monoxide and has various potential functions in physiolog-ous studies we revealed that H2S inhibits osteoblastic
transdifferentiation of vascular smooth muscle cells and valvular
interstitial cells and abrogates calcification of aortic heart valve
in ApoE deficiency in mice. Furthermore, H2S generation was found
to be reduced in valvular tissue in CAVD. We identified three
separate anti-calcification pathways for H2S: i, inhibits inorganic
phosphate uptake, ii, prevents nuclear translocation of Runx2 and
iii, increase pyrophosphate level.
The aim of this study was to examine whether inhibition of aor-




All chemicals were analytical reagent grade or higher and
obtained from Sigma-Aldrich, (St Louis, MO, USA). The sulfide donor
molecule used in thisworkAP72 (4methoxyphenyl) (piperidin-1-
yl) phosphinodithioc acid) –was synthesized in-house [22–24]. Sul-
fide stock solutions were prepared fresh daily in water.
Cell isolation and culture
Cusps of human aortic valve leaflets were obtained between
December 2018 to December 2019 (48 patients) (Regional
Research Ethical Committee, Project No.: 3853–2013 and 4699–
2016) from surgical specimens from patients undergoing complete
aortic valve replacement for significant stenosis with calcification
(referred to as aortic valve with stenosis (AS) for this study). Cells
were isolated from human heart valves by collagenase (600 U/mL)
(EMD Millipore Corp.; 234155-100MG) and cultured as previously
described [25]. Since phenols are capable to absorb a high amount
of H2S from liquids [26] our experiments were carried out in phe-
nol red-free media.
Healthy heart valves
Healthy aortic valves (HAV) for controls were obtained from
cadavers (N = 3) of suicide or traumatic eventswithout cardiovascu-
lar diseases from Department of Forensic Medicine, University of
Debrecen (Regional Research Ethical Committee, Project No.:
5038–2018).
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cVIC cells were purchased from Innoprot Ltd. (Parque Tec-
nológico de Bizkaia, Batch #0960; Spain). The cells were derived
from a healthy 8 years old Caucasian male.
Animals
All procedures followedwere inaccordancewith theethical stan-
dards of the responsible committee on human experimentation (in-
stitutional and national) and with the Helsinki Declaration of 1975,
as revised in 2008. Informed consent was obtained from all patients
for being included in the study. Animal experiments performed in
this studywere approved by the Scientific and Research Ethics Com-
mittee of the Scientific Council of Health of the Hungarian Govern-
ment under the registration number of DE MÁB/157–5/2010 and
the Institutional and National Guidelines for the care and use of ani-
mals (fisheries) were followed. C57BL/6 ApoE-/- mice were main-
tained at the University of Debrecen under specific pathogen-free
conditions in accordancewith guidelines from the Institutional Eth-
ical Committee. Mice were randomly divided into four groups. Non-
high fat diet group (N = 7) received a standard chow diet. To induce
aortic valve inflammation and/or calcification, mice were kept
atherogenic diet (15% fat, 1.25% cholesterol, ssniffSpezialdiäten
GmbH, Soest, Germany) at the age of 8 weeks. Parallel with the
atherogenic diet mouse was injected intraperitoneally with AP72
(266 mmol/kg body weight; N = 7) or vehicle (saline; N = 7) in every
other day as previously described. Aortas were collected after
8weeks of treatment. For the detection of the inflammatory process
in vivo, mice were euthanized every second week until 8 weeks. All
micewere euthanized by a predictable and controllable administer-
ing slow-fill compressed CO2 asphyxiation. Atherogenic food com-
position (high-fat diet): Crude Nutrients (%): Crude protein 19%;
crude fat 15.2%; crudefiber 3.4%; crude ash 6.3%; starch 25.6%; sugar
11.2%; Additives (per kg): vitamin A 15,000 IU; vitamin D3 1,000 IU;
vitamin E 110 mg; vitamin K3 5 mg; vitamin C 0 mg; copper 13 mg.
Alizarin Red s staining for determination of extracellular calcium
deposition
Alizarin Red S (Sigma Aldrich; A5533) staining was used to visu-
alize the calcium deposition. Plates were fixed with 3%
paraformaldehyde and stored at 4 C for 10 min and stained with
a 2% solution of Alizarin Red S. All calcific nodules in each well
were then manually counted under a microscope. To quantify the
calcified area we used imageJ software.
Western blot analysis
To detect NF-jB, Runx2, TNF-a and IL1-b were used rabbit anti-
human TNF-a (Thermo Fisher Scientific; PA5-19810; 400 ng/mL);
rabbit anti-human IL1-b (Invitrogen; 17h18l16; 400 ng/mL), rabbit
anti-human Runx2 (Proteintech; 20700–1-AP; 60 ng/mL), and
rabbit anti-human NF-jB (Cell Signaling Technology; D14E12;
400 ng/mL). Next, HRP-labeled anti-rabbit IgG antibody was used
as a secondary antibody. Complexes of antigen–antibody were
visualized with a horseradish peroxidase chemiluminescence
detection system (Amersham Biosciences; RPN2109). Membranes
were reprobedwith glyceraldehyde-3-phosphate dehydrogenase
(GAPDH).
Quantitative Real-Time PCR (qRT-PCR)
VIC were cultured in growth media or calcification media sup-
plemented with 20 mmol/L AP72. After 5 days cells were harvested.
Total RNA was isolated using RNAzol STAT-60 according to themanufacturer’s instructions (TEL-TEST Inc., Friendswood, TX,
USA). RNA concentration was measured with NanoDropTM 2000c
spectrophotometer (Thermo Scientific Inc., Waltham, MA, USA).
Subsequently, cDNA synthesis was performed using a high-
capacity cDNA kit (Applied Biosystems, Foster City, CA). We used
real-time PCR technique for quantification of mRNA levels of IL1-
b and TNF-a (Thermo Fisher Scientific Inc.) and GAPDH (Thermo
Fisher Scientific Inc.). TaqMan Universal PCR Master Mix was pur-
chased from Applied Biosystems (Applied Biosystems, Foster City,
CA). Finally, we performed TaqMan quantitative PCR (40 cycles at
95 C for 15 sec. and 60 C for 1 min.) on 96-well plates with the
Bio-Rad CFX96 (Bio-Rad Laboratories Inc., Hercules, California,
USA) detection system. Results were expressed as mRNA expres-
sion normalized to GAPDH.
Immunohistochemistry
Heart valve tissues were fixed with formaldehyde for one day
followed by TRIS buffer and embedded in paraffin wax. Subse-
quently, slides were deparaffinized in xylene for 5 min and then
rehydrated. For immunohistochemistry, slides were subjected to
a peroxidase-blocking reagent for 5 min (3% hydrogen peroxide
was used to block endogenous peroxidase activity). Antigen retrie-
val was performed in an epitope retrieval solution (Leica RE-7113)
at pH 6 using a pressure cooker (rice programs, IDA Avair 6 L pres-
sure cooker). Von Kossa staining and the follow IHC stains were
performed with the following antibodies: rabbit anti-human
TNF-a (Thermo Fisher Scientific; PA5-19810; 400 ng/mL); rabbit
anti-human IL1-b (Invitrogen; 17h18l16; 400 ng/mL). Antibody
binding was visualized by the Super Sensitive TM One Step
Polymer-HRP IHC Detection System. The intensity and distribution
of antibodies expression were assessed by light microscopy (Leica
DM2500 microscope, DFC 420 camera and Leica Application Suite
V3 software, Wetzlar, Germany).
Immunohistochemistry from mouse heart valves
Briefly,mouse heart valve tissueswere fixed in formaldehyde for
one day followed by TRIS buffer and embedded in paraffinwax. Sub-
sequently, slideswere deparaffinized in xylene and then rehydrated.
For immunohistochemistry, slides were subjected to the
peroxidase-blocking reagent. Von Kossa staining and the following
stains were performed with the following primary antibodies:
anti-IL-1b antibody (Invitrogen; 17h18l16;
400 ng/mL), anti-TNF-a antibody (Thermo Fisher Scientific; PA5-
19810; (400 ng/mL). Antibody binding was visualized by the Super
Sensitive TM One Step Polymer-HRP IHC Detection System. Liquid
DAB chromogen (BG-QD630-XAKmBioGenex) were added for sam-
ples. The intensity and distribution of antibodies expression were
assessed by light microscopy (Leica DM2500 microscope, DFC 420
camera and Leica Application Suite V3 software,Wetzlar, Germany).
Immunofluorescence staining
VIC were cultured on the coverslip and treated with or without
calcification medium in the absence of phenol red, supplemented
with 20 mmol/L AP72 for 5 days. After treatment, the cells were
fixed with 3.7% formaldehyde for 15 min. After fixation, cells were
blocked with 10% goat serum for 1 h at room temperature. Rabbit
polyclonal anti-human NF-jB (Cell Signaling Technology; D14E12;
400 ng/mL) was used as a primary antibody to showing NF-jB
localization in VIC. Primary antibodies labeled with goat anti-
rabbit Alexa 488 (Thermo Fisher Scientific, A11070) as fluorophore
for 1 h in dark at room temperature. Hoechst was used to stain
nuclei. Multicolor STED imaging was acquired with STED (Stimu-
lated Emission Depletion) Leica TCS SP8 gated STED-CW nanoscopy
168 K. Éva Sikura et al. / Journal of Advanced Research 27 (2021) 165–176(Leica Microsystem Mannheim, Germany). Gated STED images
were deconvolved using Huygens Professional (Scientific Volume
Imaging B.V., Hilversum, Netherlands) software. Colocalization rate
of NF-jB of the samples were measured by Image J software.
Nuclear and cytoplasmic protein extraction
Cells were cultured in growth medium and treated with or
without calcification medium supplemented with 20 lmol/L
AP72. After treatment, cells were harvested with cell scraper and
collected into a centrifuge tube. Pellets were washed twice with
PBS and then ice-cold 1  cytoplasmic lysis buffer (20 mmol/L
Tris–HCl pH 8.0, 100 mmol/L NaCl, 300 mmol/L sucrose, 3 mmol/
L MgCl2, protease inhibitor cocktail) was added to the pellets. Cell
suspensions were incubated on ice for 15 min. After centrifugation,
the supernatants were collected (contains cytoplasmic proteins);
the pellets were washed with PBS and resuspended in ice-cold
nuclear extraction buffer (20 mmol/L Tris–HCl pH 8.0, 300 mmol/
L NaCl, 2 mmol/L EDTA pH 8.0, protease inhibitor cocktail). After
that, the samples were passed five times through a 27 gauge nee-
dle, for the extraction of the nuclear proteins followed by centrifu-
gation at 8,000  g, 4 C for 20 min. The supernatant contains the
nuclear fraction. The protein concentration of the samples was
determined by the BCA Protein Detection Kit (Amersham).
CSE, CBS and NF-jB gene silencing
CSE, CBS and NF-jB genes were silenced, using appropriate siR-
NAs. Briefly, the VIC were cultured on 12-well plates in antibiotic-
free medium (DMEM, Sigma). At about 70% of confluence, cells
were transfected with siRNA against CSE and CBS (CSE: Ambion,
4392420; s3710; CBS: Ambion, 4390824; s289). NF-jB gene silenc-
ing using siRNA (Ambion, 4392420; s9505) was performed. Trans-
fection occurred for 4 hr in minimal serum-content medium (Opti-
MEM; Gibco). At the end of transfection, 30% FBS containing
antibiotic-free DMEM was added. Next day, cells were washed
and treated with AP72 every second day until 5 days.
Pharmacological inhibition of NF-jB
VIC were cultured in 12-well plates in growth medium or calci-
fication medium in the absence of phenol-red. Inhibition of NF-jB
was carried out with the relevant inhibitor SC75741 (Sigma
Aldrich, Cat# SML2382-MG). The inhibitor was used at 5 nmol/L).
Statistical analysis
Datawere analyzed by GraphPad Prism 5.02 software (GraphPad
Software Inc., 7825 FayAvenue, Suite 230 La Jolla, CA 92037). All sta-
tistical data are expressed asmean ± SEM. If data groups passed nor-
mality test and equal variance test, we performed Student’s t-test or
OneWay ANOVA followed by Bonferroni post hoc tests as indicated
in figure legends. P < 0.05 was considered significant.
Results
Pro-inflammatory cytokines are expressed in human calcified stenotic
aortic valves
To show inflammation is present in human calcified stenotic
aortic valves (AS), we stained heart valves derived from patient
underwent aortic valve replacement for cytokines, IL-1b and
TNF-a. For controls, we obtained healthy aortic valves (HAV) from
cadavers of suicide or traumatic events without cardiovascular dis-
eases. Strong von Kossa staining indicated a severe valvular calcifi-cation in AS. As shown in Fig. 1A, mineralization was accompanied
by increased expression of IL-1b and TNF-a in AS compared to
HAV. Western blot analysis also demonstrated higher levels of
pro-inflammatory cytokines (IL1-b and TNF-a) in AS compared to
HAV (Fig. 1B). These data are accordance with the previously
revealed observations, namely inflammation and calcification are
hallmarks in CAVD [1].
Exogenous H2S prevents inflammation in aortic valves of
apolipoprotein E deficient mice
Since we previously demonstrated that H2S inhibits aortic valve
calcification in apolipoprotein E deficient mice (ApoE-/- mice) kept
on a high-fat diet [3,27] we tested whether it also affects inflam-
mation of aortic valves of ApoE-/- mice kept on a high-fat diet.
We utilized AP72, a slow-releasing H2S donor, previously found
to be a potent inhibitor of valvular mineralization, in our experi-
ments [3]. Administration of AP72 intraperitoneally significantly
inhibited the thickening of the aortic valves and the expression
of inflammatory cytokines IL1-b and TNF-a (Fig. 2A). Similarly, to
human AS (Fig. 1A), the number of cells stained for IL1-b and
TNF-a were pronounced in aortic valves of ApoE-/- mice fed with
a high-fat diet. As shown in Fig. 2A, AP72 treatment significantly
reduced the expression of both IL1-b and TNF-a in aortic valve tis-
sue of ApoE-/- mice fed with a high-fat diet. Similar findings were
observed in ex vivo conditions, as we employed high phosphate
exposure to provoke calcification in valves of ApoE-/- mice. Alizarin
Red S staining demonstrated a significant attenuation of calcifica-
tion of valvular interstitial cells (Fig. 2B) treated with AP72.
As expected, calcification of human valvular interstitial cells
also occurred in response to high phosphate. Surprisingly, both
IL1-b and TNF-a were induced in human interstitial cells main-
tained in high phosphate (Fig. 3A and B). Treatment of cells with
AP72 significantly inhibited the accumulation of calcium deposits
in extracellular matrix, and that was accompanied by the abolish-
ment of the induction of pro-inflammatory cytokines (Fig. 3A-C).Reduction of endogenous H2S production enhances phosphate-
provoked inflammation in valvular interstitial cells
We recently observed that mitigation of endogenous H2S pro-
duction by lowering CSE and CBS expression promotes calcification
of valvular interstitial cells [3]. Therefore, to test whether the anti-
inflammatory effect of endogenously produced H2S also exist we
performed experiments employing double silencing of CSE and
CBS. We found that using interfering RNAs for CSE/CBS signifi-
cantly enhanced the expression of both IL1-b and TNF-a in human
vascular interstitial cells (Fig. 3A and B) exposed to high phosphate
suggesting that H2S controls the progress of inflammation under
calcifying conditions.
Suppression of inflammatory processes by H2S occurs via inhibiting the
activation of NF-jB
It is well established that NF-jB regulates pro-inflammatory
signaling pathway and its activation is based on its nuclear translo-
cation followed by pro-inflammatory cytokine expressions such as
interleukin 1b (IL-1b) and tumor necrosis factor a (TNF-a) [19]. It
has been shown that H2S capable of transsulfuration of inhibitor-
jB resulting in an inhibition of nuclear translocation of NF-jB
[20,28,29]. Thus, we examined whether AP72 affects the activation
of NF-jB in cells maintained in calcifying condition. Confocal
microscopy and immunofluorescence staining indicated that NF-
jB was located in the cytoplasm of valvular interstitial cells cul-




























































































































































































Fig. 1. Inflammatory cytokines are characteristic of human stenotic aortic valve. A) Hematoxylin and eosin, von Kossa, TNF-a and IL1-b IHC staining were performed on HAV
valves derived from the Department of Forensic Institute, University of Debrecen (upper images; N = 3) and on AS valves (lower images, N = 5). Scale bars (50 mm and 20 mm)
and pixel intensity of IHC staining were shown. Representative staining was shown. B) IL1-b and TNF-a protein expression in HAV and AS heart valve tissue was assessed by
western blot analysis. Protein expressions were normalized to GAPDH. Results were analyzed by One Way ANOVA, Bonferroni’s Multiple Comparison Test and were shown as
mean values ± SEM of five independent experiments. *P < 0.01; ***P < 0.0001.
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from the cytoplasm to the nucleus (Fig. 4A; middle panels). As
demonstrated in Fig. 4A (lower panel) AP72 prevented the appear-
ance of NF-jB in the nucleus of valvular interstitial cells main-
tained in calcification medium. To confirm our
immunofluorescence finding, cytoplasm and nucleus fractions ofvalvular interstitial cells were examined for NF-jB employing
western blot analysis. We found that NF-jB appeared in the
nucleus in response to phosphate exposure (Fig. 4B) while its level
was decreased in the cytoplasmic fraction. Importantly, AP72
treatment prevented the translocation of NF-jB into the nucleus

















































































































Fig. 2. Hydrogen sulfide inhibits inflammation and calcification. A) TNF-a and IL1-b staining were performed on aortic valves of ApoE-/- mice kept on high-fat diet (upper
panels, N = 5) and on high-fat diet treated with AP72 (lower panels; N = 5). B) Alizarin Red S staining was performed in ex vivo cultured aortic valves of ApoE-/- mice cultured
in growth medium or calcification medium in the absence or presence with AP72 were shown. Results were analyzed by One Way ANOVA, Bonferroni’s Multiple Comparison
Test and were shown as mean values ± SEM of five independent experiments. **P < 0.001; ***P < 0.0001.














































































































































































































Fig. 3. Hydrogen sulfide controls pro-inflammatory cytokines expression. A) IL1-b, B) TNF-a western blot and RT-qPCR were performed and normalized to GAPDH. C) VIC
cultured in growth medium or calcification medium in the absence or presence with AP72. Representative Alizarin Red S staining of human AS derived VIC was shown. VIC
were cultured in growth medium or calcification medium. Western blots were carrying out from CSE and CBS double gene silencing utilizing siRNA. D) IL1-b and E) TNF-a
western blot was showing. Western blots were normalized to GAPDH. Results were analyzed by One Way ANOVA, Bonferroni’s Multiple Comparison Test and were shown as
mean values ± SEM of five independent experiments. *P < 0.01; **P < 0.001; ***P < 0.0001.





















































































































Fig. 4. Supplementation of AP72 suppresses nuclear translocation of NF-jB. VIC were grown on coverslips and were exposed to growth medium or calcification medium in
the absence or presence with AP72. A) Cells were stained with Hoechst 33,258 for DNA (blue) an anti-NF-jB antibody with Alexa Flour 488 secondary antibody (green).
Images were taken with Leica TCS SP8 gated STED-CW nanoscopy. Images were deconvolved using Huygens Professional software. Colocalization rate (right panel) of
nucleus/NF-jB was shown in the right panel of Fig. 5A. B) Expression of NF-jB in cytoplasmic and nuclear fraction of VIC was shown. The intensity of bands was normalized
to Lamin B1 in case of nuclear extracts and for GAPDH in case of cytoplasm extracts. Results were analyzed by One Way ANOVA, Bonferroni’s Multiple Comparison Test and
were shown as mean values ± SEM of five independent experiments. Ns.: not significant; *P < 0.01; **P < 0.001.
172 K. Éva Sikura et al. / Journal of Advanced Research 27 (2021) 165–176NF-jB activation triggers Runx2 nuclear translocation and subsequent
mineralization of valvular interstitial cells
Runx2 is a key transcription factor associated with an early
osteoblastic differentiation of vascular smooth muscle cells and
valvular interstitial cells. We were curious whether there is a linkbetween NF-jB and Runx2 in human valvular interstitial cells in
calcific conditions. We cultured human valvular interstitial cells
in calcifying media where the NF-jB gene was silenced. As
expected nuclear translocation of Runx2 occurred in cells in
response to phosphate exposure. To our surprise, silencing NF-jB




















































































































































































































































































Fig. 5. NF-jB gene silencing decreases the nuclear translocation of Runx2. VIC were cultured in growth medium or calcification medium. NF-jB gene silencing using siRNA
was performed. A) Runx2 expression in cytoplasmic and nuclear fraction of VIC was shown. The intensity of bands was normalized for Lamin B1 in case of nuclear extracts and
for GAPDH in the case of cytoplasm extracts. B) Alizarin Red S staining was shown. Pharmacological inhibition of NF-jB by SC75741 was performed. C) NF-jB and D) Runx2
protein expression in cytoplasmic and nuclear fraction of VIC were shown. The intensity of bands was normalized for Lamin B1 in case of nuclear extracts and for GAPDH in
case of cytoplasm extracts. Results were analyzed by One Way ANOVA, Bonferroni’s Multiple Comparison Test and were shown as mean values ± SEM of five independent
experiments. Ns.: not significant; *P < 0.01; **P < 0.001; ***P < 0.0001.
K. Éva Sikura et al. / Journal of Advanced Research 27 (2021) 165–176 173(siRNA) markedly decreased nuclear translocation of Runx2
(Fig. 5A). To confirm this observation, we employed a pharmaco-
logical inhibitor of NF-jB (SC75741). As shown in Fig. 5C, treat-
ment of cells with the synthetic NF-jB inhibitor SC75741
significantly reduced the nuclear appearance of Runx2 (Fig. 5C).
To further collect evidence that inflammatory process in valvularinterstitial cells regulates mineralization via NF-jB, we cultured
cells in calcifying conditions where the NF-jB gene was silenced
and followed the accumulation of calcium in extracellular matrix.
Importantly, silencing of NF-jB inhibited deposition of calcium
in extracellular matrix of valvular interstitial cells maintained in
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Fig. 6. Hydrogen sulfide attenuates NF-jB and Runx2 in heart valves of ApoE-/- mice. ApoE-/- mice fed with high-fat diet. Control mice were injected intraperitoneally with
saline for 4 weeks or 8 weeks; H2S treated mice were injected intraperitoneally with AP72 for 8 weeks. Heart valves of ApoE-/- mice were stained with Hoechst 33,258 for DNA
(blue) an anti-NF-jB antibody with Alexa Flour 488 secondary antibody (green) and an anti-Runx2 antibody with Alexa Flour 647 secondary antibody (red). A) Double
immunofluorescence staining of NF-jB and Runx2 was performed. B) High magnification images of mouse heart valve were taken with Leica TCS SP8 gated STED-CW
nanoscopy. Images were deconvolved using Huygens Professional software. NF-jB and Runx2 color intensity were shown. Nuclear NF-jB and Runx2 colocalization rate were
shown. NF-jB/ Runx2 colocalization rate was shown. Colocalization rates were calculated by ImageJ software. Results were analyzed by One Way ANOVA, Bonferroni’s
Multiple Comparison Test and were shown as mean values ± SEM of five independent experiments. *P < 0.01; **P < 0.001; ***P < 0.0001.
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and Runx2 in valvular interstitial cells occur during aortic valve
calcification in apolipoprotein E deficient mice - both are inhib-
ited by H2S
In apolipoprotein E deficient mice kept on high-fat diet valvular
calcification appears [3] and that is accompanied by valvular
inflammation (Fig. 1) as it was earlier revealed in CAVD [30]. Since
in our in vitro experiments H2S inhibited nuclear translocation of
both NF-jB and Runx2, and translocation of Runx2 was shown to
be dependent on NF-jB, we examined their localization in aortic
valves of ApoE-/- mice kept on a high-fat diet with or without
administration of AP72. As demonstrated by dual immunohisto-
chemistry the expression of NF-jB and Runx2 was pronounced
by 8 weeks in aortic valves of ApoE-/- mice kept on a high-fat diet
(Fig. 6A). Treatment of animals with AP72 resulted in significantly
less staining for both NF-jB and Runx2 in aortic valve tissue. Con-
focal microscopy revealed that NF-jB and Runx2 were mainly
located in the perinuclear area of cells at 4 weeks, and they were
translocated into the nucleus by 8 weeks. Employing STED nano-
scopy on valvular samples indicated that NF-jB and Runx2 were
colocalized in perinuclear region and the nucleus (Colocalization
rate: 60.75% ± 7%). AP72 treatment of ApoE-/- mice kept on a
high-fat diet prevented nuclear appearance of NF-jB and Runx2
in valvular interstitial cells (Fig. 6A and B).Discussion conclusion
This study is the first that highlights the relationship between
NF-jB and Runx2 as a link between inflammation and vascular
mineralization, and we report how hydrogen sulfide controls
cytokines expression and subsequently abrogates calcification of
aortic valve as well as inhibits osteoblastic transformation of
valvular interstitial cells. It has been revealed that CAVD is accom-
panied by calcification and inflammation resulting in heterogene-
ity of the affected aortic valve tissue. The ratio of the calcified
and non-calcified regions provides a guide in distinguishing the
state of mineralization [31–35]. CAVD is an active and well-
regulated inflammatory disease, in which inflammation is a critical
initiation step involved in valvular disease as shown by the
National Heart Lung and Blood Institute [14] and other research
groups [9,14,16,35–39] although, specific molecular mechanisms
are not fully understood.
Increasing number of evidences indicates the key role of osteo-
genic transcription factor Runx2 in cardiovascular calcification
including CAVD [3,14,30,40,41]. For instance, the increase in
intracellular phosphate level promotes nuclear translocation of
Runx2 resulting in transition of cells towards an osteoblast phe-
notype [14]. Upregulation of Runx2 was identified to be a mal-
adaptive response during injury to the vasculature, in uremic
milieu, and hyperglycemic conditions [42] and was suggested to
be both a mediator and a potential therapeutic target in vascular
mineralization [43]. In our previous studies [3,30] and others’
[3,14,30,41,42] Runx2 was found to be manifested in the nucleus
of valvular tissue cells in CAVD indicating the presence of an early
signal for transformation of valvular interstitial cells into
osteoblast-like cells.
We have shown that endogenous production of H2S by CSE and
CBS and H2S releasing molecules such as AP72 exhibit an inhibition
on aortic valve calcification in ApoE-/- mouse and transdifferentia-
tion of human valvular interstitial cells toward osteoblast-like cells
[3]. Three separate anti-calcification pathways for H2S was
observed. i, inhibition of nuclear translocation of Runx2, ii, lower-
ing inorganic phosphate uptake, and iii, increasing pyrophosphate
generation. These previous studies and our findings prompted us
to examine whether lowering inflammation by H2S might con-tribute to the inhibition of mineralization of aortic valve and such
a benefit occur via regulating Runx2 in valvular interstitial cells.
AP72 has an excellent water solubility and very slow generation
of H2S compared to the fast H2S releasing donors such as Na2S and
NaSH [28,44,45]. It is increasingly recognized that slow-releasing
H2S donors potentially better mimic the effects of the endogenous
H2S buffer system, because of their slow generation of low sulfide
levels [24,28,29]. Therefore, we employed AP72 for our experi-
ments. Importantly, exogenous source of H2S abrogated inflamma-
tion of aortic valves of ApoE-/- mice provoked by a high-fat diet
(Fig. 2) as reflected by lowering TNF-a and IL-b. Accordingly, rise
of TNF-a and IL-b levels induced by phosphate was abolished by
treatment of human valvular interstitial cells with AP72. To investi-
gatewhether endogenousH2S production has an anti-inflammatory
effect, we silenced the expression of CSE and CBS. Since the interac-
tion among CSE/CBS expression was revealed by Nandi and Mishra,
demonstrating that CBS deficiency upregulates CSE protein levels
[46], we employed double silencing. Reduction of endogenous H2S
production enhanced phosphate-provoked elevation of TNF-a and
IL-b levels in valvular interstitial cells indicating a control of inflam-
mation by the endogenous production of H2S.
Expression of pro-inflammatory cytokines, IL-1b and TNF-a are
regulated by NF-jB via its nuclear translocation [19]. It has been
recently revealed that activation of NF-jB is inhibited by H2S
[20]. This study prompted us to test whether inflammation and
calcification is connected at the level of master transcription fac-
tors, NF-jB and Runx2. Corroborate the above findings, AP72 pre-
vented the translocation of NF-jB into the nucleus in valvular
interstitial cells exposed to phosphate (Fig. 4). We also observed
that activation of Runx2 is inhibited by H2S [3]. Therefore, we
silenced NF-jB as well as employed in NF-jB inhibitor then fol-
lowed activation of Runx2 in valvular interstitial cells exposed to
phosphate. Importantly, phosphate failed to induce translocation
of Runx2 into nuclei in cells lacking NF-jB indicating a link
between pro-inflammatory signaling pathway and osteogenic sig-
naling pathway. Using in vivo approaches, we further revealed that
the expression of NF-jB and Runx2 were upregulated during aortic
valve calcification in ApoE-/- mice and both are prevented by H2S
(Fig. 6). Strong colocalization was observed between NF-jB and
Runx2 in the perinuclear region and the nuclei in valvular intersti-
tial cells during the progression of aortic valve calcification (Fig. 6).Conclusion
Our study suggests that regulation of Runx2 by H2S (CSE/CBS)
occurs via NF-jB resulting in an anti-calcification action and there-
fore establishing a link between inflammation and mineralization
in CAVD.
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